1 citations
,
January 2019 in “Digital Commons @ Olivet (Olivet Nazarene University)” Alpha mangostin may protect certain breast cancer cells by activating the p53 pathway.
1 citations
,
January 2018 in “Springer eBooks” The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.
1 citations
,
April 2016 in “Journal of The American Academy of Dermatology” Blood pressure medications may increase the risk of skin cancer.
1 citations
,
January 2004 in “Medicina de Familia SEMERGEN” Finasteride may help prevent prostate cancer.
No link was found between hair patterns and prostate cancer risk in South Indian men.
February 2026 in “Psycho-Oncologie” Alopecia areata causes significant psychological distress in cancer patients, needing integrated care.
January 2026 in “The Breast Journal” Understanding specific symptoms in different cancer stages can improve personalized care and quality of life.
September 2025 in “International Journal of Research in Medical Sciences” Chemotherapy can harm kidneys in breast cancer patients.
May 2025 in “Dermatology Online Journal” Erlotinib can cause excessive eyelash growth.
January 2025 in “UiTM Institutional Repositories (Universiti Teknologi MARA)” Christia vespertilionis extract may help fight breast cancer cells.
August 2024 in “Asian Journal of Research in Chemistry” Repurposing existing drugs can improve cancer treatment but faces challenges.
April 2024 in “Journal of biomedical and pharmaceutical research” Nanoparticles offer significant benefits over traditional chemotherapy for cancer treatment.
August 2023 in “Frontiers in Oncology” New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.
July 2023 in “Panacea Journal of Medical Sciences” Chemotherapy often causes skin, hair, and nail problems in cancer patients.
July 2023 in “LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)” Copaiba resin oil shows promise for cancer therapy and is safe for topical use.
Flubendazole in a nanoemulsion can potentially treat lung cancer and cryptococcal meningitis effectively and safely.
July 2021 in “Research Square (Research Square)” Semecarpus anacardium leaf extract fights breast cancer and extends survival in mice.
November 2020 in “UNC Libraries” Seven new genetic risk areas for prostate cancer were found.
July 2018 in “IP Indian Journal of Clinical and Experimental Dermatology” Chemotherapy often causes hair loss, so patients should be counseled to reduce anxiety.
January 2016 in “Munich Personal RePEc Archive (Ludwig Maximilian University of Munich)” A new method using gold nanoshells and infrared light effectively delivers siRNA to cancer and stem cells with precision and minimal damage.
September 2010 in “European Urology Supplements” Serum triglyceride levels are not linked to prostate cancer risk.
March 2009 in “The Journal of Urology” Low dose finasteride causes only small changes in PSA levels in older men with BPH.
September 2007 in “MacSphere (McMaster University)” New biomarkers and targets for breast cancer treatment were identified to help prevent relapse and metastasis.
June 2007 in “Nature Clinical Practice Urology” Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.
The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.
June 2003 in “Obstetrical & Gynecological Survey” Examining more lymph nodes can improve survival rates in breast cancer patients without lymph node involvement.
May 1994 in “Reactions Weekly” Many medications can cause hair loss or excessive hair growth, which is usually reversible after stopping the drug.
January 1994 in “Toxicological Sciences” Lower dosages of 2-(difluoromethyl)-dl-ornithine might reduce side effects, supporting further research.
January 1987 in “Journal of steroid biochemistry/Journal of Steroid Biochemistry” Norethisterone (jenapharm) therapy is effective for endometrial cancer.
1461 citations
,
March 2004 in “Annals of oncology” Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.